An $8 million false ad class settlement between Neuriva memory supplement consumers and Reckitt Benckiser LLC offers nearly nothing for the class while disproportionately benefiting their lawyers, an objecting class member and a consumer advocacy group told a Florida federal court.
David Williams and others alleged Reckitt Benckiser and RB Health (US) LLC deceptively touted the brain booster as “backed by science” and “clinically proven” to improve brain performance when there is no scientific or clinical proof that Neuriva provides any benefit to the brain.
In April, Magistrate Judge Jonathan Goodman of the U.S. District Court for the Southern District ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.